TABLE 4.
Isolate | Endornaviruses | Mycelial growth inhibition (%) at | ||||||
Famoxadone (μg ml–1) + 1 mM PG | ||||||||
0.0015 | 0.015 | 0.15 | 1.5 | 15 | 150a | 300b | ||
CH98APS060 | PEV2&PEV3 | 23.5 | 18.5 | 18.5 | 100.0 | 100.0 | 100.0 | 100.0 |
CH98APS060-a | PEV2&PEV3#c | 0.0 | 15.8 | 12.6 | 100.0 | 100.0 | 100.0 | 100.0 |
CH98ASP059 | PEV2&PEV3 | 0.0 | 0.0 | 2.1 | 100.0 | 100.0 | 100.0 | 100.0 |
CH98ASP059-L | PEV2#&PEV3#c | 0.0 | 0.0 | 0.0 | 14.1* | 21.5 | 32.3* | 27.9* |
aThe recommended concentration for commercial use.bTwo times the recommended concentration for commercial use. c# Invisible by EtBr staining (0.5 mg/ml) but detected by RT-PCR. PEV2; 14.3 kb, PEV3;13.8 kb. * indicate groups that differ significantly (p < 0.05) according to the Tukey–Kramer range test.